oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2019 ( 224 )

2018 ( 284 )

2017 ( 244 )

2016 ( 331 )

Custom range...

Search Results: 1 - 10 of 124686 matches for " Adriana Peterson Mariano Salata Rom?o "
All listed articles are free for downloading (OA Articles)
Page 1 /124686
Display every page Item
Impact of Chronic Pelvic Pain on Female Sexual Function  [PDF]
Adriana Peterson Mariano Salata Romo, Ricardo Gorayeb, Gustavo Salata Romo, Omero Benedicto Poli-Neto, Antonio Alberto Nogueira
International Journal of Clinical Medicine (IJCM) , 2013, DOI: 10.4236/ijcm.2013.43031
Abstract:

The objective of the present study was to determine the prevalence of sexual dysfunction and depression in women with chronic pelvic pain (CPP). A case-control study was conducted on 66 women, 36 of them with CPP and 30 without this diagnosis. Depression was evaluated using the Beck Depression Inventory (BDI) and sexual dysfunction was evaluated using the Female Sexual Function Index (FSFI). Data were analyzed statistically by the Mann-Whitney test, Fisher exact test, chisquare test, and Spearman correlation test. Regarding sociodemographic data, no significant differences were detected between populations with respect to the variables studied (age, schooling, number of children, income, salary, and marital status), indicating group homogeneity and thus increasing the reliability of the data. A cut-off of 26.55 points was used to calculate the total score for sexual function. In the group of women with CPP, 94.4% were at high risk for sexual dysfunction. Comparison of FSFI scores showed that the domains of sexual function, such as orgasm, lubrication and pain differed significantly between women with and without CPPP. Correlations were detected between the following items: orgasm × age (r = -0.01904), orgasm × number of children (r =-0. 00947), orgasm × body mass index (BMI) (r =-0.00 955), relationship × age (r = 0.03952), income × relationship (r =-0.014680), relationship × number of children (r =-0.03623), depression × relationship (r =-0.16091), desire × age (r = -0.45255), desire × number of children (r = -0.01824), lubrication × excitement (r = 0.04198), and lubrication × BMI (r = -0.01608). The prevalence of depression detected in the present study was 38.9% among women with pain and 3.3% among control women. It was observed that women with CPP suffer a negative interference regarding sexual function compared to controls. Thus, it can be seen that a specific approach related to sexuality is extremely important within the context of women with CPP. Depression was clearly associated with CPP and therefore an interdisciplinary approach is fundamental in order to solve this problem.

Impact of Pregnancy on the Sex Life of Women: State of the Art  [PDF]
Liliam Renata Silveira Santiago, Lucia Alves da Silva Lara, Adriana Peterson Mariano Salata Romo, Maria Fernanda Barbirato da Mata Tiezzi, Ana Carolina Japur de Sá Rosa e Silva
International Journal of Clinical Medicine (IJCM) , 2013, DOI: 10.4236/ijcm.2013.45045
Abstract:
Introduction: Women’s sexual function is a complex ensemble of variables that involve physical, emotional, and psychosocial states. Objective: This review aims to evaluate the evidence about the sexual behavior of women during pregnancy. Methods: Survey of PubMed for the period from 1996 to 2011 for prospective, retrospective and case-control studies, randomized clinical trials, meta-analyses and systematic reviews on the sexual function of women during pregnancy using the terms sexual function, sexual dysfunction, sexuality, pregnancy, andpregnant woman. Results: Changes occur in the sexual function of women during pregnancy; however, due to the heterogeneity of the studies and the incomparability of samples for lack of pairing for cultural, age, length of relationship and gestational age variables, and other methodological biases, it is not possible to characterize the sexual response of pregnant women. Conclusions: The changes observed are not sufficient to characterize sexual behavior during pregnancy as pathological. It is therefore necessary to standardize the study groups and the
Caracteriza??o clínica e psicossocial da clientela de um ambulatório de esterilidade
Gorayeb, Ricardo;Borsari, Andréa Cristina de Toledo;Gomes, Andreza Cristiana Ribeiro;Romo, Adriana Peterson Mariano Salata;Shuhama, Rosana;
Estudos de Psicologia (Campinas) , 2009, DOI: 10.1590/S0103-166X2009000300002
Abstract: the objective of this study was to describe the demographic, clinical and psychosocial characteristics of sterility clinic outpatients and to identify motivation for psychological care. it is a retrospective study, conducted using 50 couples, interviewed at the beginning of the medical inquiry process. eighty percent of the couples were in their first marriage, 64% had been married for up to 8 years, 72% had no children and 78% had been trying to conceive for up to 6 years. the causes of infertility were unknown in thirty-six percent of the couples and 78% had never being subjected to assisted reproduction procedures. ninety-four percent of the couples showed an interest in participating in a psychological support group. the fear of abortion, fetal malformation and delivery was statistically more frequent than fears related to pregnancy, assisted reproduction procedures and the responsibilities of parenthood. these data reveal significant variables for the development of interventions based on the knowledge of patients' circumstances.
Abordagem das disfun??es sexuais femininas
Lara, Lúcia Alves da Silva;Silva, Ana Carolina Japur de Sá Rosa e;Romo, Adriana Peterson Mariano Salata;Junqueira, Flavia Raquel Rosa;
Revista Brasileira de Ginecologia e Obstetrícia , 2008, DOI: 10.1590/S0100-72032008000600008
Abstract: sexual dysfunction prevalence is high among women. however, doctors rarely ask about their patients' sexual life, because they feel uncomfortable or because their knowledge about investigation techniques is insufficient. the plissit model, a useful tool to access human sexual function, is composed by four elements: permission, limited information, specific suggestions, and intensive therapy, that favor dialogue between the doctor and the patient allowing the access to the sexual complaints. the therapeutics consists of counseling measures, drug prescription, basic orientations about sexual function and interventions on anatomic and functional aspects of the sexual apparatus with positive impact in the woman's sexual life. the present review shows how to use it. in addition, many aspects of female sexual dysfunction are discussed, such as prevalence, diagnostic and treatment options for female sexual dysfunction.
The Impact of Chronic Pelvic Pain in Women  [PDF]
Adriana P. M. S. Romo, Ricardo Gorayeb, Gustavo Salata Romo, Omero Benedicto Poli-Neto, Antonio Alberto Nogueira
International Journal of Clinical Medicine (IJCM) , 2013, DOI: 10.4236/ijcm.2013.410076
Abstract:

Chronic pelvic pain (CPP) is a prevalent condition with a significant impact on the personal, social, professional and marital life of women. It is a complex condition that may have no specific causal diagnosis or may be associated with multiple diagnoses, frequently involving treatment failure. The definition of health care strategies fundamentally depends on the way women live with this condition. Thus, the objective of the present study is to learn how women with CPP experience their diagnosis and the meaning they attribute to it. A qualitative study was conducted by interviewing a focus group of 11 women. The content of the interviews was recorded and fully transcribed, and the speeches were interpreted by Bardin’s content analysis. The topics most frequently dealt with in the interview were diagnosis, beginning of pain, worsening and improving factors, marital and interpersonal relationships, interference with daily activities, association with emotional aspects, and perspectives for the future. It could be perceived how much these women need to be better heard and how much the association between psychic and physical questions must be visualized by the professionals who provide care for them. The approach used by professionals from different areas, when properly structured, can minimize the problem of the division of a sick person into separate parts. Psychological care is very important, especially in relation to the discovery of more effective strategies for living with pain.

Isoformas de Prolactina no Fluido Folicular de Pacientes Submetidas a FIV
Romo Gustavo Salata
Revista Brasileira de Ginecologia e Obstetrícia , 2000,
Abstract:
Uso de antagonista de GnRH (cetrorelix) em dose única para evitar ovula es prematuras em ciclos de fertiliza o assistida
Rosan Pedro Luís,Romo Gustavo Salata,Reis Rosana Maria dos,Moura Marcos Dias de
Revista Brasileira de Ginecologia e Obstetrícia , 2003,
Abstract: OBJETIVO: verificar a eficácia de uma dose única subcutanea de acetato de cetrorelix em evitar a ovula o prematura em ciclos de fertiliza o assistida. MéTODOS: estudo prospectivo, randomizado e controlado, pelo qual foram avaliados 20 ciclos de estimula o ovariana em mulheres submetidas a fertiliza o assistida, 10 das quais utilizaram o esquema tradicional de bloqueio hipofisário com análogos de GnRH em doses diárias (grupo controle) e 10 utilizaram antagonista de GnRH em dose única de 3 mg no 7o dia de estimula o ovariana (grupo cetrorelix). Foram dosados FSH, LH, estradiol e progesterona no soro no primeiro e sétimo dia da estimula o, no dia da inje o de HCG e no dia da capta o de oócitos. Os grupos foram comparados entre si quanto a eficácia do bloqueio hipofisário (nível de progesterona no dia da aplica o do HCG) e desempenho nos ciclos de fertiliza o assistida (ampolas de gonadotrofinas utilizadas, folículos maiores que 18 mm, oócitos captados, taxas de fertiliza o, implanta o e gravidez) utilizando os testes de Mann-Whitney e exato de Fisher. RESULTADOS: n o houve diferen a significativa entre os grupos controle e cetrorelix, respectivamente, para a mediana da idade (31,5 e 34 anos), índice de massa corpórea (24 e 22), ampolas de gonadotrofinas utilizadas (34 e 32), folículos recrutados (3,5 e 3,0), oócitos captados (11 e 5), embri es obtidos (4 e 3), taxas de fertiliza o (93,7 e 60%, p = 0,07) e gravidez (50 e 60%, p = 0,7). Em ambos os grupos observou-se bloqueio hipofisário eficaz durante o período de estimula o ovariana. CONCLUS ES: estes resultados confirmam a eficácia da dose única de 3 mg de acetato de cetrorelix em prevenir ovula es prematuras em pacientes submetidas a fertiliza o assistida, mostrando tendência a obten o de menor número de embri es e menores taxas de fertiliza o no grupo cetrorelix em rela o ao grupo controle. As taxas de implanta o e gravidez foram semelhantes entre os dois grupos. Estudos prospectivos com maior número de pacientes s o necessários para confirmar estes achados.
Uso de antagonista de GnRH (cetrorelix) em dose única para evitar ovula??es prematuras em ciclos de fertiliza??o assistida
Rosan, Pedro Luís;Romo, Gustavo Salata;Reis, Rosana Maria dos;Moura, Marcos Dias de;Ferriani, Rui Alberto;
Revista Brasileira de Ginecologia e Obstetrícia , 2003, DOI: 10.1590/S0100-72032003000800004
Abstract: purpose: to verify the efficacy of a single subcutaneous dose of cetrorelix acetate to avoid premature ovulation in assisted fertilization cycles. methods: this is a prospective, controlled and randomized study, with 20 women undergoing ovarian stimulation for assisted fertilization, 10 of whom were submitted to classical gnrh agonist protocol (control group) while 10 utilized a 3-mg subcutaneous dose of the gnrh antagonist on the 7th day of ovarian stimulation (cetrorelix group). serum fsh, lh, estradiol and progesterone concentrations were assessed on the first, seventh, hcg administration and oocyte retrieval days. both groups were compared for pituitary suppression (progesterone concentration on hcg day) and assisted fertilization cycle performance (gonadotropin ampoules utilized, follicles over 18 mm, retrieved oocytes, fertilization, implantation and pregnancy rates), utilizing mann-whitney and fisher exact tests. results: no significant difference was observed between control and cetrorelix groups, respectively, for medians of age (31.5 and 34 years), body mass index (24 and 22), gonadotropin ampoles utilized (34 and 32), follicles over 18 mm (3.5 and 3.3), retrieved oocytes (11 and 5), obtained embryos (4 and 3), fertilization (93,7 and 60%, p=0.07) and pregnancy rates (50 and 60%, p=0.07). efficient pituitary blockade through the ovarian stimulation period was observed for both groups. conclusions: these results confirm the efficacy of a 3-mg dose of cetrorelix acetate to prevent premature ovulation in patients undergoing assisted fertilization and suggest a tendency towards a smaller number of embryos and fertilization rates in the cetrorelix group than in the control group. implantation and pregnancy rates were similar between groups. other prospective studies with a greater number of patients should be performed to confirm these results.
A síndrome dos ovários policísticos pode interferir nos resultados da fertiliza??o in vitro?
Reis, Rosana Maria dos;?ngelo, Alexandre Gon?alves De;Romo, Gustavo Salata;Santana, Laura Ferreira;Moura, Marcos Dias de;Ferriani, Rui Alberto;
Revista Brasileira de Ginecologia e Obstetrícia , 2004, DOI: 10.1590/S0100-72032004000900009
Abstract: purpose: to evaluate the results of ovulation hyperinduction followed by in vitro fertilization (ivf) in women with polycystic ovary syndrome (pos), as compared to normal cycle women. methods: a controlled retrospective study conducted on 36 women with pos (pos group) and on 44 women with infertility due to mild male factor (control group), submitted to ivf from 1997 to 2003. subject ages ranged from 18 to 36 years. ovulation hyperinduction was obtained with recombinant follicle-stimulating hormone and a gonadotrophin-releasing hormone agonist. the analyzed variables were the follicles with a mean diameter of 14 to 17 mm and the follicles with diameters of 18 mm or above on the day of human chorionic gonadotrophin administration, percentage of follicles >18 mm, the number of retrieved oocytes, fertilization rate, cleavage rate, incidence of ovarian hyperstimulation syndrome (ohs), clinical pregnancy rate, and abortion rate. the variables were analyzed by the unpaired t test, fisher exact test and mann-whitney test, with level of significance set at p<0.05. results: the pos group presented a larger number of retrieved follicles, most of them measuring 14 to 17 mm in diameter, compared to the control group (64.8 vs 53.9%), a lower fertilization rate (59.43 vs 79.57%) and a higher incidence of ohs (38.9 vs 9.1%). the number of retrieved oocytes, cleavage rates, pregnancy rates per embryo transfer, abortion rates and live born rates did not differ between groups. conclusion: the success of ivf is impaired in women with pos due to their larger number of retrieved follicles of reduced diameter, reduced fertilization rate and high ohs rates.
Freqüência de infec??o pelo Mycoplasma hominis e Ureaplasma urealyticum em mulheres inférteis e rela??o com repercuss?es clínicas
Penna, Ivan Araujo;Duarte, Geraldo;Ferriani, Rui Alberto;Machado, Alcyone Artioli;Romo, Gustavo Salata;Reis, Rosana Maria dos;Moura, Marcos Dias de;
Revista Brasileira de Ginecologia e Obstetrícia , 2005, DOI: 10.1590/S0100-72032005000200004
Abstract: purpose: to determine the frequency of mycoplasma hominis and ureaplasma urealyticum infection, and relate it to the associated clinical variables of infertile women. methods: transversal study involving 322 infertile women, submitted to collection of endocervix swab for research of mycoplasma hominis and ureaplasma urealyticum infecction, from october 2002 to may 2004. all patients were submitted to a basic infertility investigation protocol. as control, a historical series of 51 non-pregnant women previously investigated as for the studied infectious agents, was used. results: the frequency of mycoplasma hominis and ureaplasma urealyticum infection was 4.9% in the infertile women and 13.8% in the control group. among the infertile patients, a relationship between the presence of the two agents and changes in the histerosalpingography result (or: 3.20; ic 95%: 1.05-9.73), presence of dyspareunia (or: 10.72; ic 95%: 3.21-35.77) and vaginal discharge (or: 8.5; ic 95%: 2.83-26.02), besides endocervical culture positive for escherichia coli (or: 6.09; ic 95%: 4.95-52.25) was observed. conclusion: mycoplasma hominis and ureaplasma urealyticum infection rate is low in infertile patients and is associated with reproductive sequels.
Page 1 /124686
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.